Expand BIB Menu
BIB MENU

BIB ETF Profile


Family: ProShares
Name: ProShares Ultra Nasdaq Biotechnology
Inception Date: 7-Apr-2010
Termination Date:
Investment Objective: ProShares Ultra Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index.
Prospectus
Top 10 Holdings
Derivatives offset -125.5251%
NASDAQ Bio Index SWAP BNP 42.2824%
NASDAQ Biotechnology Index SWAP UBS AG 37.4213%
TREASURY BILL 912797GK7 18.9373%
NASDAQ Biotechnology Index SWAP Bank of America NA 17.3522%
NASDAQ Biotechnology Index SWAP Societe Generale 12.6160%
NASDAQ Biotechnology Index SWAP Goldman Sachs International 6.8753%
Net Other Assets (Liabilities) 6.4817%
AMGEN INC AMGN 6.3331%
VERTEX PHARMACEUTICALS INC VRTX 6.1726%
Top 10 Holdings Weight: 28.9%
Number of Holdings: 230
Shares Outstanding: 1,625,000
Total Net Assets: 78,016,250
NAV: 47.96
Net Expense Ratio: 0.95%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Biotech
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor: Leveraged (2x)
Is Currency Hedged: No
US or Ex-US: Domestic